The goal of this observational study is to learn about the effects of antiplatelet drugs on patients over the age of 80 with atrial fibrillation. The main question it aims to answer is:
-Is platelet reactivity effectively controlled in patients over the age of 80 diagnosed with atrial fibrillation following the Watchman procedure.
Inclusion Criteria:
Exclusion Criteria:
mholinst@med.umich.edu734-764-4046
Patients over the age of 80 diagnosed with atrial fibrillation receiving ether aspirin alone or aspirin and clopidogrel
Anticoagulation Therapy in the Very Old
Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly
Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?
New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study
The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF)
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE